John Galgiani, MD, director of the University of Arizona Valley Fever Center for Excellence and professor in the UArizona College of Medicine – Tucson, was honored as the inaugural recipient of the Distinguished Director’s Award and one of 25 faculty members singled out for excellence in teaching, scholarship and outreach.
Author Archive: AZBioPEERS Team
TGEN Names Kevin Campbell Chief Information Officer
Phoenix, AZ — Aug. 17, 2022 — The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that industry veteran Kevin Campbell has been appointed the Institute’s Chief Information Officer.
Booth Udall Fuller Offer Intellectual Property Office Hours for AZBio Members
In partnership with Arizona BioIndustry Association (AZBio), Booth Udall are offering weekly office hours to give AZBio members the opportunity to ask questions about the protection of their intellectual property assets and general considerations for their IP strategy.
Arizona Commerce Authority offering a registration reimbursement grant for TechConnect Conference 2022
TechConnect is the premier SBIR conference where companies across the country gather to hear from experts and connect directly with SBIR program managers. Many companies credit the experience and knowledge they gained from attending with helping them submit a successful SBIR application.
The Arizona Commerce Authority understands that the cost of travel and accommodations may not be feasible for everyone, so they are offering a registration reimbursement
Preclinical studies show Aqualung Therapeutic’s eNAMPT- targeting ALT-100 mAb to reduce severity of aggressive prostate cancer
Preclinical prostate cancer (PCa] studies published in the December 17th, 2021 issue of Pharmaceuticals show Aqualung Therapeutic’s ALT-100 mAb to significantly improve overall survival and to reduce distal metastases in SCID mice implanted with human prostate cancer (PCa] cells. Aqualung Therapeutics is an early stage immunotherapeutics company with an anti-inflammatory therapeutic platform to address life-threatening unchecked inflammation.
UACI Sponsorship Launch Program – Apply Today
Through collaboration and sponsorship with Perkins Coie LLP, UACI is offering a sponsored year at the incubator for one deserving startup with a committed team that is working to solve a significant business or social challenge. The winning team will also receive a cash award of $15,000, which includes funding for a legal project budget. The total prize package is valued at $25,000.
$3,000 Grants available for SBIR submissions- SBA FAST Program
Arizona’s FAST program funds resources, training and network opportunities to aid entrepreneurs in their SBIR proposal success. Grants will be distributed in three rounds from October 2021 to September 2022. Each round will award six applicants up to $3,000 each.
Surveillance of Wastewater and Prevention Platform (SWAPP): A Case Study of Digital Public Health and SARS-CoV-2
InerOme, University of California San Diego, and Fry Laboratories published an article in the Journal of Precision Medicine, detailing a cloud based digital health Surveillance of Wastewater and Prevention Platform for COVID-19.
HybridChart Partners with athenahealth’s Marketplace Program to Bring Workflow Efficiency Solution to Rounding Physicians
Scottsdale, AZ – September 23, 2021 – HybridChart, a leading solutions provider for charge capture and workflow management, announced a partnership with athenahealth, Inc. joining the company’s Marketplace program. As part of the athenahealth® Marketplace, the EVOLVE product by HybridChart is a newly integrated application now available to athenahealth’s growing network of healthcare providers.Continue reading
Nationwide study of 295,000 brain cancer patients examines differences due to age and sex
Study by TGen and collaborators documents different outcomes for males and females at various ages
PHOENIX, Ariz. — Sept. 22, 2021 — Findings from a national study by researchers at Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and external collaborators suggest that sex and age are crucial factors in the care and survival of patients with malignant brain tumors and other central nervous system (CNS) cancers.